USE OF MIDAZOLAM IN PAEDIATRIC DENTISTRY
Authors:
J. Vašáková 1; E. Dokoupilová 2; P. Poláčková 1,3
Authors place of work:
Stomatologická klinika, Univerzita Karlova, 3. lékařská fakulta, a Fakultní nemocnice Královské Vinohrady, Praha
1; Stomatologická klinika, Univerzita Karlova, 1. lékařská fakulta, a Všeobecná fakultní nemocnice v Praze
2; Stomatologická klinika, Univerzita Karlova, Lékařská fakulta v Plzni, a Fakultní nemocnice Plzeň
3
Published in the journal:
Česká stomatologie / Praktické zubní lékařství, ročník 123, 2023, 1, s. 3-9
Category:
Review Article
doi:
https://doi.org/10.51479/cspzl.2023.002
Summary
Introduction and aim: Midazolam is a short-acting, effective sedative with a rapid onset and minimal side effects, belonging to the benzodiazepine group. The work deals with the use of the midazolam in the dental treatment of children, the history of which dates back to the 1990s. The reason for its popularity in treating children is mainly its sedative and amnestic effects which help both children to cope with the treatment and doctors to cope with the emotional burden, that treating children undoubtedly is. Furthermore, it has a short half-life time and the oral route of administration is preferred by children. The authors describe the physical properties, mechanism of action, pharmacokinetics and the most common side and adverse effects of midazolam. The authors perceive the inconsistency of the professional public in the view, procedure, dosage, and the extent of treatment in sedation while aware of the application of midazolam in children. The aim of the work is to revise the current indications and contraindications for the treatment of paediatric patients in conscious sedation with midazolam, with the help of the available literature, with regard to the age of the child, the extent and nature of the performed procedure. Also, to discuss the methods of administration and safe course of midazolam in outpatient practice.
Methods: The literature search and survey was focused on the keywords “midazolam“, “dental treatment“, “children“, and “conscious sedation“. The PubMed database was used to find it. Furthermore, we drew information from the specialized books dealing with the given topic. The available literature was subsequently critically evaluated for the needs of this review.
Conclusion: Treatment of children is often complicated by the fear of dental treatment. The appropriate method of midazolam administration in the suitable background offers a safe, fast, affordable, and effective treatment option of conscious sedation with minimum side effects. When properly indicated, it can be of a great help in gaining the children´s cooperation.
Keywords:
dental treatment – children – midazolam – conscious sedation
Zdroje
1. Kupietzky A, Houpt MI. Midazolam: a review of its use for conscious sedation of children. Pediatr Dent. 1993; 15(4): 237–241.
2. Giovannitti JA. Midazolam: Review of a versatile agent for use in dentistry. Anest Prog. 1987; 34(5): 164–170.
3. Lee SK. Diagnosis and treatment of status epilepticus. J Epilepsy Res. 2020; 10(2): 45–54.
4. Pacifici GM. Clinical pharmacology of midazolam in neonates and children: effect of disease – a review. Int J Pediatr. 2014; 2014: 309342. doi: 10.1155/2014/309342
5. Prommer E. Midazolam: an essential palliative care drug. Palliat Care Soc Pract. 2020; 2020(14): 2632352419895527. doi: 10.1177/2632352419895527
6. Sivaramakrishnan G, Sridharan K. Nitrous oxide and midazolam sedation: A systematic review and meta-analysis. Anesth Prog. 2017; 64(2): 59–65.
7. Pansini V, Curatola A, Gatto A, Lazzareschi I, Ruggiero A, Chiaretti A. Intranasal drugs for analgesia and sedation in children admitted to pediatric emergency department: a narrative review. Ann Transl Med. 2021; 9(2): 189.
8. Flores-Perez C, Moreno-Rocha LA, Chavez-Pacheco JL, Noguez-Mendez NA, Flores-Perez J, Alcantara-Morales MF, et al. Sedation level with midazolam: A pediatric surgery approach. Saudi Pharm J. 2022; 30(7): 906–917.
9. Jones RD, Chan K, Roulson CJ, Brown AG, Smith ID, Mya GH. Pharmacokinetics of flumazenil and midazolam. Br J Anaesth. 1993; 70(3): 286–292.
10. Payne KA, Coetzee AR, Mattheyse FJ. Midazolam and amnesia in pediatric premedication. Acta Anaesthesiol Belg. 1991; 42(2): 101–105.
11. Sievers TD, Yee JD, Foley ME, Blanding PJ, Berde CB. Midazolam for conscious sedation during pediatric oncology procedures: safety and recovery parameters. Pediatrics. 1991; 88(6): 1172–1179.
12. Ashley P, Anand P, Andersson K. Best clinical practice guidance for conscious sedation of children undergoing dental treatment: an EAPD policy document. Eur Arch Paediatr Dent. 2021; 22(6): 989–1002.
13. Uldum B, Hallonsten AL, Poulsen S. Midazolam conscious sedation in a large Danish municipal dental service for children and adolescents. Int J Paediatr Dent. 2008; 18(4): 256–261.
14. Bailey AM, Baum RA, Horn K, Lewis T, Morizio K, Schultz A, et al. Review of intranasally administered medications for use in the emergency department. J Emerg Med. 2017; 53(1): 38–48.
15. Vasakova J, Duskova J, Lunackova J, Drapalova K, Zuzankova L, Starka L, et al. Midazolam and its effect on vital signs and behavior in children under conscious sedation in dentistry. Physiol Res. 2020; 69(Suppl 2): S305–S314.
16. Dripps DR. American Society for Anesthesiologists. New classification of physical status. Anesthesiology. 1963; 24: 111.
17. Manso MA, Guittet C, Vandenhende F, Granier LA. Efficacy of oral midazolam for minimal and moderate sedation in pediatric patients: A systematic review. Pediatr Anesth. 2019; 29(9): 1–13.
18. Payne K, Mattheyse FJ, Liebenberg D, Dawes T. The pharmacokinetics of midazolam in paediatric patients. Eur J Clin Pharmacol. 1989; 37(3): 267–272.
19. Alfonzo-Echeverri E, Troutman KC, George W. Absorption and elimination of midazolam by submucosal and intramuscular routes. Anesth Prog. 1990; 37(6): 277–281.
20. Rantavuori K. Aspects and determinants of children´s dental fear. disertace. 2008: 19–20.
21. Alwin NP, Murray JJ, Britton PG. An assessment of dental anxiety in children. Br Dent J. 1991; 171(7): 201–207.
22. Berge MT, Veerkamp JSJ, Hoogstraten J. The etiology of childhood dental fear: the role of dental and conditioning experiences. J Anxiety Dis. 2002; 16(3): 321–329.
23. Česká stomatologická komora. Odborné stanovisko představenstva Komory č. 1/2021 k sedaci v dětské stomatologii. [cit. 1. 11. 2022]. Dostupné z: https://old. dent.cz/wp-content/uploads/2022/01/ eapd guidelines_on_sedation_in_peadiatric_ dentistry-_rev_2021.pdf
Štítky
Maxillofacial surgery Orthodontics Dental medicineČlánok vyšiel v časopise
Czech Dental Journal
2023 Číslo 1
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- The Importance of Limosilactobacillus reuteri in Administration to Diabetics with Gingivitis
Najčítanejšie v tomto čísle
- USE OF MIDAZOLAM IN PAEDIATRIC DENTISTRY
- MANUAL TOOTHBRUSHES – BRISTLES QUALITY
- PERI-IMPLANTITIS: CLASSIFICATION, ETIOLOGY AND PREVENTION
- ČASOPIS ČSPZL: NOVÝ WEB A REDAKČNÍ SYSTÉM